Correlation Between Scpharmaceuticals and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Seres Therapeutics, you can compare the effects of market volatilities on Scpharmaceuticals and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Seres Therapeutics.
Diversification Opportunities for Scpharmaceuticals and Seres Therapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Scpharmaceuticals and Seres is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Seres Therapeutics
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Seres Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 2.79 times less risky than Seres Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Seres Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 84.00 in Seres Therapeutics on November 2, 2024 and sell it today you would earn a total of 2.00 from holding Seres Therapeutics or generate 2.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Seres Therapeutics
Performance |
| Timeline |
| Scpharmaceuticals |
| Seres Therapeutics |
Scpharmaceuticals and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Seres Therapeutics
The main advantage of trading using opposite Scpharmaceuticals and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |